Literature DB >> 28573668

Establishing a chemical genetic link between Bruton tyrosine kinase activity in malignant B cells and cell functions involved in the micro-environmental dialogue.

Elisa Göckeritz1, Verena Vondey1, Anna Guastafierro1, Maja Pizevska1, Floyd Hassenrück1, Lars Neumann1, Michael Hallek1, Günter Krause1.   

Abstract

To elucidate their mechanism of action, inhibitors of Bruton tyrosine kinase (BTK) and resistant BTK mutants were employed to dissect target-dependent cellular functions. BTK-C481S and -T474I, expressed in Ramos and NALM-6 cells, maintained BTK auto-phosphorylation under treatment with ibrutinib or dasatinib, respectively, which showed only modest cytotoxicity. Retained activity of BTK-T474 partially rescued cell migration from inhibition by dasatinib. Importantly, resistant BTK mutants reconstituted B cell receptor-triggered chemokine secretion in the presence of corresponding inhibitors, demonstrating that BTK activity is connected with cell-intrinsic functions of malignant B cells with importance for their dialogue with the micro-environment.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  B cell malignancies; chemokine secretion; chemotaxis; resistance mutations; tyrosine kinase inhibitors

Mesh:

Substances:

Year:  2017        PMID: 28573668     DOI: 10.1111/bjh.14781

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Constitutive activation of Lyn kinase enhances BCR responsiveness, but not the development of CLL in Eµ-TCL1 mice.

Authors:  Viktoria Kohlhas; Michael Hallek; Phuong-Hien Nguyen
Journal:  Blood Adv       Date:  2020-12-22

2.  Cell line-based assessment of BTK inhibitors.

Authors:  Günter Krause; Floyd Hassenrück; Michael Hallek
Journal:  Br J Pharmacol       Date:  2020-01-28       Impact factor: 8.739

Review 3.  Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib.

Authors:  Günter Krause; Floyd Hassenrück; Michael Hallek
Journal:  Drug Des Devel Ther       Date:  2018-08-21       Impact factor: 4.162

Review 4.  New roles for B cell receptor associated kinases: when the B cell is not the target.

Authors:  Phuong-Hien Nguyen; Emanuel Niesen; Michael Hallek
Journal:  Leukemia       Date:  2019-01-30       Impact factor: 11.528

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.